TG Therapeutics | Capital Social Ordinario



Ordinary Share Capital Cambio Fecha
AbbVie USD 18M 0 2024-12
Alaunos Therapeutics USD 2K 0 2024-12
Amgen USD 538M 33.04B 2025-06
Ardelyx USD 240.77M 240.74M 2025-06
Arrowhead Research USD 138.14M 137.91M 2025-06
Bayer EUR 982.42M 1.53B 2025-06
Biogen USD 146.6M 146.5M 2025-06
Corcept Therapeutics USD 105.29M 105.15M 2025-06
Dynavax Technologies USD 117.23M 117.11M 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
J&J USD 3.12B 0 2025-03
Novartis USD 793M 0 2024-12
PTC Therapeutics USD 79.38M 79.3M 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
TG Therapeutics USD 158.02M 157.87M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


TG Therapeutics Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.